1
|
Bahloul MA, Jabeen S, Benoumhani S, Alsaleh HA, Belkhatir Z, Al‐Wabil A. Advancements in synthetic CT generation from MRI: A review of techniques, and trends in radiation therapy planning. J Appl Clin Med Phys 2024; 25:e14499. [PMID: 39325781 PMCID: PMC11539972 DOI: 10.1002/acm2.14499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2024] [Revised: 06/27/2024] [Accepted: 07/26/2024] [Indexed: 09/28/2024] Open
Abstract
BACKGROUND Magnetic resonance imaging (MRI) and Computed tomography (CT) are crucial imaging techniques in both diagnostic imaging and radiation therapy. MRI provides excellent soft tissue contrast but lacks the direct electron density data needed to calculate dosage. CT, on the other hand, remains the gold standard due to its accurate electron density information in radiation therapy planning (RTP) but it exposes patients to ionizing radiation. Synthetic CT (sCT) generation from MRI has been a focused study field in the last few years due to cost effectiveness as well as for the objective of minimizing side-effects of using more than one imaging modality for treatment simulation. It offers significant time and cost efficiencies, bypassing the complexities of co-registration, and potentially improving treatment accuracy by minimizing registration-related errors. In an effort to navigate the quickly developing field of precision medicine, this paper investigates recent advancements in sCT generation techniques, particularly those using machine learning (ML) and deep learning (DL). The review highlights the potential of these techniques to improve the efficiency and accuracy of sCT generation for use in RTP by improving patient care and reducing healthcare costs. The intricate web of sCT generation techniques is scrutinized critically, with clinical implications and technical underpinnings for enhanced patient care revealed. PURPOSE This review aims to provide an overview of the most recent advancements in sCT generation from MRI with a particular focus of its use within RTP, emphasizing on techniques, performance evaluation, clinical applications, future research trends and open challenges in the field. METHODS A thorough search strategy was employed to conduct a systematic literature review across major scientific databases. Focusing on the past decade's advancements, this review critically examines emerging approaches introduced from 2013 to 2023 for generating sCT from MRI, providing a comprehensive analysis of their methodologies, ultimately fostering further advancement in the field. This study highlighted significant contributions, identified challenges, and provided an overview of successes within RTP. Classifying the identified approaches, contrasting their advantages and disadvantages, and identifying broad trends were all part of the review's synthesis process. RESULTS The review identifies various sCT generation approaches, consisting atlas-based, segmentation-based, multi-modal fusion, hybrid approaches, ML and DL-based techniques. These approaches are evaluated for image quality, dosimetric accuracy, and clinical acceptability. They are used for MRI-only radiation treatment, adaptive radiotherapy, and MR/PET attenuation correction. The review also highlights the diversity of methodologies for sCT generation, each with its own advantages and limitations. Emerging trends incorporate the integration of advanced imaging modalities including various MRI sequences like Dixon sequences, T1-weighted (T1W), T2-weighted (T2W), as well as hybrid approaches for enhanced accuracy. CONCLUSIONS The study examines MRI-based sCT generation, to minimize negative effects of acquiring both modalities. The study reviews 2013-2023 studies on MRI to sCT generation methods, aiming to revolutionize RTP by reducing use of ionizing radiation and improving patient outcomes. The review provides insights for researchers and practitioners, emphasizing the need for standardized validation procedures and collaborative efforts to refine methods and address limitations. It anticipates the continued evolution of techniques to improve the precision of sCT in RTP.
Collapse
Affiliation(s)
- Mohamed A. Bahloul
- College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
- Translational Biomedical Engineering Research Lab, College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
| | - Saima Jabeen
- College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
- Translational Biomedical Engineering Research Lab, College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
- AI Research Center, College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
| | - Sara Benoumhani
- College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
- AI Research Center, College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
| | | | - Zehor Belkhatir
- School of Electronics and Computer ScienceUniversity of SouthamptonSouthamptonUK
| | - Areej Al‐Wabil
- College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
- AI Research Center, College of EngineeringAlfaisal UniversityRiyadhSaudi Arabia
| |
Collapse
|
2
|
de Leon J, Jelen U, Carr M, Crawford D, Picton M, Tran C, McKenzie L, Peng V, Twentyman T, Jameson MG, Batumalai V. Adapting outside the box: Simulation-free MR-guided stereotactic ablative radiotherapy for prostate cancer. Radiother Oncol 2024; 200:110527. [PMID: 39242030 DOI: 10.1016/j.radonc.2024.110527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2024] [Revised: 08/29/2024] [Accepted: 09/02/2024] [Indexed: 09/09/2024]
Abstract
BACKGROUND AND PURPOSE Magnetic resonance (MR)-guided radiotherapy (MRgRT) enhances treatment precision and adaptive capabilities, potentially supporting a simulation-free (sim-free) workflow. This work reports the first clinical implementation of a sim-free workflow using the MR-Linac for prostate cancer patients treated with stereotactic ablative radiotherapy (SABR). MATERIALS AND METHODS Fifteen patients who had undergone a prostate-specific membrane antigen positron emission tomography/CT (PSMA-PET/CT) scan as part of diagnostic workup were included in this work. Two reference plans were generated per patient: one using PSMA-PET/CT (sim-free plan) and the other using standard simulation CT (simCT plan). Dosimetric evaluations included comparisons between simCT, sim-free, and first fraction plans. Timing measurements were conducted to assess durations for both simCT and sim-free pre-treatment workflows. RESULTS All 15 patients underwent successful treatment using a sim-free workflow. Dosimetric differences between simCT, sim-free, and first fraction plans were minor and within acceptable clinical limits, with no major violations of standardised criteria. The sim-free workflow took on average 130 min, while the simCT workflow took 103 min. CONCLUSION This work demonstrates the feasibility and benefits of sim-free MR-guided adaptive radiotherapy for prostate SABR, representing the first reported clinical experience in an ablative setting. By eliminating traditional simulation scans, this approach reduces patient burden by minimising hospital visits and enhances treatment accessibility.
Collapse
Affiliation(s)
| | - Urszula Jelen
- GenesisCare, St Vincent's Hospital, Sydney, Australia
| | - Madeline Carr
- GenesisCare, St Vincent's Hospital, Sydney, Australia
| | | | | | - Charles Tran
- GenesisCare, St Vincent's Hospital, Sydney, Australia
| | | | - Valery Peng
- GenesisCare, St Vincent's Hospital, Sydney, Australia
| | | | - Michael G Jameson
- GenesisCare, St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Vikneswary Batumalai
- GenesisCare, St Vincent's Hospital, Sydney, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia; The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
| |
Collapse
|
3
|
Villegas F, Dal Bello R, Alvarez-Andres E, Dhont J, Janssen T, Milan L, Robert C, Salagean GAM, Tejedor N, Trnková P, Fusella M, Placidi L, Cusumano D. Challenges and opportunities in the development and clinical implementation of artificial intelligence based synthetic computed tomography for magnetic resonance only radiotherapy. Radiother Oncol 2024; 198:110387. [PMID: 38885905 DOI: 10.1016/j.radonc.2024.110387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Revised: 06/13/2024] [Accepted: 06/13/2024] [Indexed: 06/20/2024]
Abstract
Synthetic computed tomography (sCT) generated from magnetic resonance imaging (MRI) can serve as a substitute for planning CT in radiation therapy (RT), thereby removing registration uncertainties associated with multi-modality imaging pairing, reducing costs and patient radiation exposure. CE/FDA-approved sCT solutions are nowadays available for pelvis, brain, and head and neck, while more complex deep learning (DL) algorithms are under investigation for other anatomic sites. The main challenge in achieving a widespread clinical implementation of sCT lies in the absence of consensus on sCT commissioning and quality assurance (QA), resulting in variation of sCT approaches across different hospitals. To address this issue, a group of experts gathered at the ESTRO Physics Workshop 2022 to discuss the integration of sCT solutions into clinics and report the process and its outcomes. This position paper focuses on aspects of sCT development and commissioning, outlining key elements crucial for the safe implementation of an MRI-only RT workflow.
Collapse
Affiliation(s)
- Fernanda Villegas
- Department of Oncology-Pathology, Karolinska Institute, Solna, Sweden; Radiotherapy Physics and Engineering, Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Solna, Sweden
| | - Riccardo Dal Bello
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - Emilie Alvarez-Andres
- OncoRay - National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
| | - Jennifer Dhont
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Department of Medical Physics, Brussels, Belgium; Université Libre De Bruxelles (ULB), Radiophysics and MRI Physics Laboratory, Brussels, Belgium
| | - Tomas Janssen
- Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - Lisa Milan
- Medical Physics Unit, Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland
| | - Charlotte Robert
- UMR 1030 Molecular Radiotherapy and Therapeutic Innovations, ImmunoRadAI, Paris-Saclay University, Institut Gustave Roussy, Inserm, Villejuif, France; Department of Radiation Oncology, Gustave Roussy, Villejuif, France
| | - Ghizela-Ana-Maria Salagean
- Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Romania; Department of Radiation Oncology, TopMed Medical Centre, Targu Mures, Romania
| | - Natalia Tejedor
- Department of Medical Physics and Radiation Protection, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - Petra Trnková
- Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria
| | - Marco Fusella
- Department of Radiation Oncology, Abano Terme Hospital, Italy
| | - Lorenzo Placidi
- Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Rome, Italy.
| | - Davide Cusumano
- Mater Olbia Hospital, Strada Statale Orientale Sarda 125, Olbia, Sassari, Italy
| |
Collapse
|
4
|
Singhrao K, Dugan CL, Calvin C, Pelayo L, Yom SS, Chan JW, Scholey JE, Singer L. Evaluating the Hounsfield unit assignment and dose differences between CT-based standard and deep learning-based synthetic CT images for MRI-only radiation therapy of the head and neck. J Appl Clin Med Phys 2024; 25:e14239. [PMID: 38128040 PMCID: PMC10795453 DOI: 10.1002/acm2.14239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2023] [Revised: 11/22/2023] [Accepted: 11/29/2023] [Indexed: 12/23/2023] Open
Abstract
BACKGROUND Magnetic resonance image only (MRI-only) simulation for head and neck (H&N) radiotherapy (RT) could allow for single-image modality planning with excellent soft tissue contrast. In the MRI-only simulation workflow, synthetic computed tomography (sCT) is generated from MRI to provide electron density information for dose calculation. Bone/air regions produce little MRI signal which could lead to electron density misclassification in sCT. Establishing the dosimetric impact of this error could inform quality assurance (QA) procedures using MRI-only RT planning or compensatory methods for accurate dosimetric calculation. PURPOSE The aim of this study was to investigate if Hounsfield unit (HU) voxel misassignments from sCT images result in dosimetric errors in clinical treatment plans. METHODS Fourteen H&N cancer patients undergoing same-day CT and 3T MRI simulation were retrospectively identified. MRI was deformed to the CT using multimodal deformable image registration. sCTs were generated from T1w DIXON MRIs using a commercially available deep learning-based generator (MRIplanner, Spectronic Medical AB, Helsingborg, Sweden). Tissue voxel assignment was quantified by creating a CT-derived HU threshold contour. CT/sCT HU differences for anatomical/target contours and tissue classification regions including air (<250 HU), adipose tissue (-250 HU to -51 HU), soft tissue (-50 HU to 199 HU), spongy (200 HU to 499 HU) and cortical bone (>500 HU) were quantified. t-test was used to determine if sCT/CT HU differences were significant. The frequency of structures that had a HU difference > 80 HU (the CT window-width setting for intra-cranial structures) was computed to establish structure classification accuracy. Clinical intensity modulated radiation therapy (IMRT) treatment plans created on CT were retrospectively recalculated on sCT images and compared using the gamma metric. RESULTS The mean ratio of sCT HUs relative to CT for air, adipose tissue, soft tissue, spongy and cortical bone were 1.7 ± 0.3, 1.1 ± 0.1, 1.0 ± 0.1, 0.9 ± 0.1 and 0.8 ± 0.1 (value of 1 indicates perfect agreement). T-tests (significance set at t = 0.05) identified differences in HU values for air, spongy and cortical bone in sCT images compared to CT. The structures with sCT/CT HU differences > 80 HU of note were the left and right (L/R) cochlea and mandible (>79% of the tested cohort), the oral cavity (for 57% of the tested cohort), the epiglottis (for 43% of the tested cohort) and the L/R TM joints (occurring > 29% of the cohort). In the case of the cochlea and TM joints, these structures contain dense bone/air interfaces. In the case of the oral cavity and mandible, these structures suffer the additional challenge of being positionally altered in CT versus MRI simulation (due to a non-MR safe immobilizing bite block requiring absence of bite block in MR). Finally, the epiglottis HU assignment suffers from its small size and unstable positionality. Plans recalculated on sCT yielded global/local gamma pass rates of 95.5% ± 2% (3 mm, 3%) and 92.7% ± 2.1% (2 mm, 2%). The largest mean differences in D95, Dmean , D50 dose volume histogram (DVH) metrics for organ-at-risk (OAR) and planning tumor volumes (PTVs) were 2.3% ± 3.0% and 0.7% ± 1.9% respectively. CONCLUSIONS In this cohort, HU differences of CT and sCT were observed but did not translate into a reduction in gamma pass rates or differences in average PTV/OAR dose metrics greater than 3%. For sites such as the H&N where there are many tissue interfaces we did not observe large scale dose deviations but further studies using larger retrospective cohorts are merited to establish the variation in sCT dosimetric accuracy which could help to inform QA limits on clinical sCT usage.
Collapse
Affiliation(s)
- Kamal Singhrao
- Department of Radiation OncologyBrigham and Women's Hospital, Dana‐Farber Cancer Institute, Harvard Medical SchoolBostonMassachusettsUSA
| | - Catherine Lu Dugan
- Department of Radiation OncologyUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| | - Christina Calvin
- Department of Radiation OncologyUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| | - Luis Pelayo
- Department of Radiation OncologyUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| | - Sue Sun Yom
- Department of Radiation OncologyUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| | - Jason Wing‐Hong Chan
- Department of Radiation OncologyUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| | | | - Lisa Singer
- Department of Radiation OncologyUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| |
Collapse
|
5
|
Carr ME, Jelen U, Picton M, Batumalai V, Crawford D, Peng V, Twentyman T, de Leon J, Jameson MG. Towards simulation-free MR-linac treatment: utilizing male pelvis PSMA-PET/CT and population-based electron density assignments. Phys Med Biol 2023; 68:195012. [PMID: 37652043 DOI: 10.1088/1361-6560/acf5c6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Accepted: 08/31/2023] [Indexed: 09/02/2023]
Abstract
Objective. This study aimed to investigate the dosimetric impact of using population-based relative electron density (RED) overrides in lieu of simulation computerized tomography (CT) in a magnetic resonance linear accelerator (MRL) workflow for male pelvis patients. Additionally, the feasibility of using prostate specific membrane antigen positron emission tomography/CT (PSMA-PET/CT) scans to assess patients' eligibility for this proposed workflow was examined.Approach. In this study, 74 male pelvis patients treated on an Elekta Unity 1.5 T MRL were retrospectively selected. The patients' individual RED values for 8 organs of interest were extracted from their simulation-CT images to establish population-based RED values. These values were used to generate individual (IndD) and population-based (PopD) RED dose plans, representing current and proposed MRL workflows, respectively. Lastly, this study compared RED values obtained from CT and PET-CT scanners in a phantom and a subset of patients.Results. Population-based RED values were mostly within two standard deviations of ICRU Report 46 values. PopD plans were comparable to IndD plans, with the average %difference magnitudes of 0.5%, 0.6%, and 0.6% for mean dose (all organs), D0.1cm3(non-target organs) and D95%/D98% (target organs), respectively. Both phantom and patient PET-CT derived RED values had high agreement with corresponding CT-derived values, with correlation coefficients ≥ 0.9.Significance. Population-based RED values were considered suitable in a simulation-free MRL treatment workflow. Utilizing these RED values resulted in similar dosimetric uncertainties as per the current workflow. Initial findings also suggested that PET-CT scans may be used to assess prospective patients' eligibility for the proposed workflow. Future investigations will evaluate the clinical feasibility of implementing this workflow for prospective patients in the clinical setting. This is aimed to reduce patient burden during radiotherapy and increase department efficiencies.
Collapse
Affiliation(s)
- Madeline E Carr
- GenesisCare, New South Wales, Australia
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | | | | | - Vikneswary Batumalai
- GenesisCare, New South Wales, Australia
- School of Clinical Medicine, Medicine and Health, University of New South Wales, Australia
| | | | | | | | | | - Michael G Jameson
- GenesisCare, New South Wales, Australia
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
- School of Clinical Medicine, Medicine and Health, University of New South Wales, Australia
| |
Collapse
|
6
|
McNaughton J, Fernandez J, Holdsworth S, Chong B, Shim V, Wang A. Machine Learning for Medical Image Translation: A Systematic Review. Bioengineering (Basel) 2023; 10:1078. [PMID: 37760180 PMCID: PMC10525905 DOI: 10.3390/bioengineering10091078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Revised: 07/30/2023] [Accepted: 09/07/2023] [Indexed: 09/29/2023] Open
Abstract
BACKGROUND CT scans are often the first and only form of brain imaging that is performed to inform treatment plans for neurological patients due to its time- and cost-effective nature. However, MR images give a more detailed picture of tissue structure and characteristics and are more likely to pick up abnormalities and lesions. The purpose of this paper is to review studies which use deep learning methods to generate synthetic medical images of modalities such as MRI and CT. METHODS A literature search was performed in March 2023, and relevant articles were selected and analyzed. The year of publication, dataset size, input modality, synthesized modality, deep learning architecture, motivations, and evaluation methods were analyzed. RESULTS A total of 103 studies were included in this review, all of which were published since 2017. Of these, 74% of studies investigated MRI to CT synthesis, and the remaining studies investigated CT to MRI, Cross MRI, PET to CT, and MRI to PET. Additionally, 58% of studies were motivated by synthesizing CT scans from MRI to perform MRI-only radiation therapy. Other motivations included synthesizing scans to aid diagnosis and completing datasets by synthesizing missing scans. CONCLUSIONS Considerably more research has been carried out on MRI to CT synthesis, despite CT to MRI synthesis yielding specific benefits. A limitation on medical image synthesis is that medical datasets, especially paired datasets of different modalities, are lacking in size and availability; it is therefore recommended that a global consortium be developed to obtain and make available more datasets for use. Finally, it is recommended that work be carried out to establish all uses of the synthesis of medical scans in clinical practice and discover which evaluation methods are suitable for assessing the synthesized images for these needs.
Collapse
Affiliation(s)
- Jake McNaughton
- Auckland Bioengineering Institute, University of Auckland, 6/70 Symonds Street, Auckland 1010, New Zealand; (J.M.)
| | - Justin Fernandez
- Auckland Bioengineering Institute, University of Auckland, 6/70 Symonds Street, Auckland 1010, New Zealand; (J.M.)
- Department of Engineering Science and Biomedical Engineering, University of Auckland, 3/70 Symonds Street, Auckland 1010, New Zealand
| | - Samantha Holdsworth
- Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Auckland 1023, New Zealand
- Centre for Brain Research, University of Auckland, 85 Park Road, Auckland 1023, New Zealand
- Mātai Medical Research Institute, 400 Childers Road, Tairāwhiti Gisborne 4010, New Zealand
| | - Benjamin Chong
- Auckland Bioengineering Institute, University of Auckland, 6/70 Symonds Street, Auckland 1010, New Zealand; (J.M.)
- Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Auckland 1023, New Zealand
- Centre for Brain Research, University of Auckland, 85 Park Road, Auckland 1023, New Zealand
| | - Vickie Shim
- Auckland Bioengineering Institute, University of Auckland, 6/70 Symonds Street, Auckland 1010, New Zealand; (J.M.)
- Mātai Medical Research Institute, 400 Childers Road, Tairāwhiti Gisborne 4010, New Zealand
| | - Alan Wang
- Auckland Bioengineering Institute, University of Auckland, 6/70 Symonds Street, Auckland 1010, New Zealand; (J.M.)
- Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Auckland 1023, New Zealand
- Centre for Brain Research, University of Auckland, 85 Park Road, Auckland 1023, New Zealand
| |
Collapse
|
7
|
O'Connor LM, Quinn A, Denley S, Leigh L, Martin J, Dowling JA, Skehan K, Warren-Forward H, Greer PB. Cone beam computed tomography image guidance within a magnetic resonance imaging-only planning workflow. Phys Imaging Radiat Oncol 2023; 27:100472. [PMID: 37720461 PMCID: PMC10500022 DOI: 10.1016/j.phro.2023.100472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 07/06/2023] [Accepted: 07/06/2023] [Indexed: 09/19/2023] Open
Abstract
Background and purpose Magnetic Resonance Imaging (MRI)-only planning workflows offer many advantages but raises challenges regarding image guidance. The study aimed to assess the viability of MRI to Cone Beam Computed Tomography (CBCT) based image guidance for MRI-only planning treatment workflows. Materials and methods An MRI matching training package was developed. Ten radiation therapists, with a range of clinical image guidance experience and experience with MRI, completed the training package prior to matching assessment. The matching assessment was performed on four match regions: prostate gold seed, prostate soft tissue, rectum/anal canal and gynaecological. Each match region consisted of five patients, with three CBCTs per patient, resulting in fifteen CBCTs for each match region. The ten radiation therapists performed the CBCT image matching to CT and to MRI for all regions and recorded the match values. Results The median inter-observer variation for MRI-CBCT matching and CT-CBCT matching for all regions were within 2 mm and 1 degree. There was no statistically significant association in the inter-observer variation in mean match values and radiation therapist image guidance experience levels. There was no statistically significant association in inter-observer variation in mean match values for MRI experience levels for prostate soft tissue and gynaecological match regions, while there was a statistically significant difference for prostate gold seed and rectum match regions. Conclusion The results of this study support the concept that with focussed training, an MRI to CBCT image guidance approach can be successfully implemented in a clinical planning workflow.
Collapse
Affiliation(s)
- Laura M O'Connor
- Department of Radiation Oncology, Calvary Mater Hospital, Edith Street, Waratah, Newcastle, NSW 2298, Australia
- School of Health Sciences, University of Newcastle, University Drive, Newcastle, NSW 2308, Australia
| | - Alesha Quinn
- Department of Radiation Oncology, Calvary Mater Hospital, Edith Street, Waratah, Newcastle, NSW 2298, Australia
| | - Samuel Denley
- Department of Radiation Oncology, Calvary Mater Hospital, Edith Street, Waratah, Newcastle, NSW 2298, Australia
| | - Lucy Leigh
- Hunter Medical Research Institute, Lot 1 Kookaburra Ct, New Lambton Heights, NSW 2305, Australia
| | - Jarad Martin
- Department of Radiation Oncology, Calvary Mater Hospital, Edith Street, Waratah, Newcastle, NSW 2298, Australia
| | - Jason A Dowling
- Australian E-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Bowen Bridge Rd, Herston, QLD 4029, Australia
| | - Kate Skehan
- Department of Radiation Oncology, Calvary Mater Hospital, Edith Street, Waratah, Newcastle, NSW 2298, Australia
| | - Helen Warren-Forward
- School of Health Sciences, University of Newcastle, University Drive, Newcastle, NSW 2308, Australia
| | - Peter B Greer
- Department of Radiation Oncology, Calvary Mater Hospital, Edith Street, Waratah, Newcastle, NSW 2298, Australia
- School of Information and Physical Sciences, University of Newcastle, University Drive, Newcastle, NSW 2308, Australia
| |
Collapse
|
8
|
La Greca Saint-Esteven A, Dal Bello R, Lapaeva M, Fankhauser L, Pouymayou B, Konukoglu E, Andratschke N, Balermpas P, Guckenberger M, Tanadini-Lang S. Synthetic computed tomography for low-field magnetic resonance-only radiotherapy in head-and-neck cancer using residual vision transformers. Phys Imaging Radiat Oncol 2023; 27:100471. [PMID: 37497191 PMCID: PMC10366636 DOI: 10.1016/j.phro.2023.100471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2023] [Revised: 07/06/2023] [Accepted: 07/06/2023] [Indexed: 07/28/2023] Open
Abstract
Background and purpose Synthetic computed tomography (sCT) scans are necessary for dose calculation in magnetic resonance (MR)-only radiotherapy. While deep learning (DL) has shown remarkable performance in generating sCT scans from MR images, research has predominantly focused on high-field MR images. This study presents the first implementation of a DL model for sCT generation in head-and-neck (HN) cancer using low-field MR images. Specifically, the use of vision transformers (ViTs) was explored. Materials and methods The dataset consisted of 31 patients, resulting in 196 pairs of deformably-registered computed tomography (dCT) and MR scans. The latter were obtained using a balanced steady-state precession sequence on a 0.35T scanner. Residual ViTs were trained on 2D axial, sagittal, and coronal slices, respectively, and the final sCTs were generated by averaging the models' outputs. Different image similarity metrics, dose volume histogram (DVH) deviations, and gamma analyses were computed on the test set (n = 6). The overlap between auto-contours on sCT scans and manual contours on MR images was evaluated for different organs-at-risk using the Dice score. Results The median [range] value of the test mean absolute error was 57 [37-74] HU. DVH deviations were below 1% for all structures. The median gamma passing rates exceeded 94% in the 2%/2mm analysis (threshold = 90%). The median Dice scores were above 0.7 for all organs-at-risk. Conclusions The clinical applicability of DL-based sCT generation from low-field MR images in HN cancer was proved. High sCT-dCT similarity and dose metric accuracy were achieved, and sCT suitability for organs-at-risk auto-delineation was shown.
Collapse
Affiliation(s)
- Agustina La Greca Saint-Esteven
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
- Computer Vision Laboratory, Department of Information Technology and Electrical Engineering, ETH Zurich, Sternwartstrasse 7, Zurich 8092, Switzerland
| | - Ricardo Dal Bello
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| | - Mariia Lapaeva
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| | - Lisa Fankhauser
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| | - Bertrand Pouymayou
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| | - Ender Konukoglu
- Computer Vision Laboratory, Department of Information Technology and Electrical Engineering, ETH Zurich, Sternwartstrasse 7, Zurich 8092, Switzerland
| | - Nicolaus Andratschke
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| | - Panagiotis Balermpas
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| | - Matthias Guckenberger
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| | - Stephanie Tanadini-Lang
- Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland
| |
Collapse
|
9
|
Eidex Z, Ding Y, Wang J, Abouei E, Qiu RL, Liu T, Wang T, Yang X. Deep Learning in MRI-guided Radiation Therapy: A Systematic Review. ARXIV 2023:arXiv:2303.11378v2. [PMID: 36994167 PMCID: PMC10055493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/31/2023]
Abstract
MRI-guided radiation therapy (MRgRT) offers a precise and adaptive approach to treatment planning. Deep learning applications which augment the capabilities of MRgRT are systematically reviewed. MRI-guided radiation therapy offers a precise, adaptive approach to treatment planning. Deep learning applications which augment the capabilities of MRgRT are systematically reviewed with emphasis placed on underlying methods. Studies are further categorized into the areas of segmentation, synthesis, radiomics, and real time MRI. Finally, clinical implications, current challenges, and future directions are discussed.
Collapse
Affiliation(s)
- Zach Eidex
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA
- School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA
| | - Yifu Ding
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA
| | - Jing Wang
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA
| | - Elham Abouei
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA
| | - Richard L.J. Qiu
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA
| | - Tian Liu
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Tonghe Wang
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Xiaofeng Yang
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA
- School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA
| |
Collapse
|